Patti E Gravitt

Author PubWeight™ 120.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009 8.26
2 Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol 2002 3.53
3 Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda. Lancet 2011 3.52
4 Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004 3.04
5 Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda. J Infect Dis 2010 2.70
6 Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck 2009 2.59
7 Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol 2008 2.51
8 Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol 2007 2.27
9 Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS 2012 2.15
10 Practice patterns in cervical cancer screening and human papillomavirus testing. Am J Clin Pathol 2012 1.81
11 Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One 2011 1.80
12 Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 2002 1.78
13 Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2. J Virol 2007 1.70
14 Circumcision of HIV-infected men and transmission of human papillomavirus to female partners: analyses of data from a randomised trial in Rakai, Uganda. Lancet Infect Dis 2011 1.69
15 Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis 2005 1.65
16 Comparison of two PCR-based human papillomavirus genotyping methods. J Clin Microbiol 2008 1.59
17 Estimating the impact of human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in Mali. Clin Infect Dis 2011 1.55
18 Absence of simian virus 40 in human brain tumors from northern India. Int J Cancer 2002 1.50
19 Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 2003 1.46
20 Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions. Cancer Epidemiol Biomarkers Prev 2003 1.44
21 Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda. Cancer Epidemiol Biomarkers Prev 2008 1.44
22 Comparability of self-collected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda. Sex Transm Dis 2007 1.43
23 The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe. AIDS 2010 1.40
24 Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women. Cancer Res 2012 1.31
25 An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS). Obstet Gynecol 2008 1.26
26 Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species. Cancer Res 2006 1.26
27 Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause 2014 1.21
28 Increased p53 immunopositivity in anaplastic medulloblastoma and supratentorial PNET is not caused by JC virus. BMC Cancer 2005 1.19
29 Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 2003 1.19
30 Comparative community outreach to increase cervical cancer screening in the Mississippi Delta. Prev Med 2011 1.18
31 Male circumcision and anatomic sites of penile high-risk human papillomavirus in Rakai, Uganda. Int J Cancer 2011 1.17
32 Human papillomavirus genotype prevalence in high-grade squamous intraepithelial lesions and colposcopically normal women from Zimbabwe. Int J Cancer 2002 1.17
33 Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. Am J Obstet Gynecol 2003 1.16
34 Human papillomavirus type distribution in cervical cancer in Delhi, India. Int J Gynecol Pathol 2006 1.13
35 Cancer patterns in nasopharyngeal carcinoma multiplex families in Taiwan. Int J Cancer 2009 1.13
36 Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms. Am J Surg Pathol 2008 1.12
37 Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries? Cancer Epidemiol 2009 1.12
38 Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India. Cancer Epidemiol Biomarkers Prev 2009 1.10
39 Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Am J Surg Pathol 2009 1.08
40 Determinants of VIA (Visual Inspection of the Cervix After Acetic Acid Application) positivity in cervical cancer screening of women in a peri-urban area in Andhra Pradesh, India. Cancer Epidemiol Biomarkers Prev 2010 1.08
41 Correlates of cervicovaginal human papillomavirus detection in perimenopausal women. J Womens Health (Larchmt) 2009 1.07
42 Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal. Vaccine 2008 1.07
43 Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. PLoS One 2013 1.07
44 Nitric oxide induces early viral transcription coincident with increased DNA damage and mutation rates in human papillomavirus-infected cells. Cancer Res 2009 1.06
45 Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Cancer Epidemiol Biomarkers Prev 2010 1.05
46 Human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in sub-Saharan Africa. AIDS 2012 1.04
47 Differences in the concentration and correlation of cervical immune markers among HPV positive and negative perimenopausal women. Cytokine 2011 1.04
48 Evaluation of a new DNA test for detection of carcinogenic human papillomavirus. J Clin Microbiol 2011 1.02
49 Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears. Am J Pathol 2009 1.02
50 Confirmation and quantitation of human papillomavirus type 52 by Roche Linear Array using HPV52-specific TaqMan E6/E7 quantitative real-time PCR. J Virol Methods 2008 1.01
51 Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe. J Infect Dis 2011 1.01
52 Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening. Obstet Gynecol 2015 1.00
53 Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests. Cancer 2008 1.00
54 Trends of human papillomavirus testing in cervical cancer screening at a large academic cytology laboratory. Obstet Gynecol 2011 0.99
55 Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens. J Clin Microbiol 2012 0.99
56 Correlates of sexual activity and sexually transmitted infections among human immunodeficiency virus-infected youth in the LEGACY cohort, United States, 2006. Pediatr Infect Dis J 2011 0.98
57 A comparison of dacron versus Flocked nylon swabs for anal cytology specimen collection. Acta Cytol 2011 0.97
58 The correlation between human papillomavirus positivity and abnormal cervical cytology result differs by age among perimenopausal women. J Low Genit Tract Dis 2013 0.97
59 Feasibility study of a human papillomavirus E6 oncoprotein test for diagnosis of cervical precancer and cancer. J Clin Microbiol 2010 0.96
60 Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009. Cancer 2014 0.96
61 Impact of improved classification on the association of human papillomavirus with cervical precancer. Am J Epidemiol 2009 0.95
62 Male circumcision decreases high-risk human papillomavirus viral load in female partners: a randomized trial in Rakai, Uganda. Int J Cancer 2013 0.95
63 Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study. Cancer Res 2010 0.93
64 Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. J Clin Microbiol 2013 0.93
65 Progesterone and 17beta-estradiol enhance regulatory responses to human papillomavirus type 16 virus-like particles in peripheral blood mononuclear cells from healthy women. Clin Vaccine Immunol 2010 0.92
66 A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study. Cancer Epidemiol Biomarkers Prev 2009 0.92
67 Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2. Am J Pathol 2008 0.92
68 The association of hormonal contraceptive use and HPV prevalence. Int J Cancer 2010 0.91
69 Comparative performance of human papillomavirus DNA testing using novel sample collection methods. J Clin Microbiol 2011 0.89
70 Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens. J Virol Methods 2013 0.89
71 Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. Int J Cancer 2013 0.89
72 Combined oral contraceptive use increases HPV persistence but not new HPV detection in a cohort of women from Thailand. J Infect Dis 2011 0.87
73 Human papillomavirus-type distribution in women with and without cervical neoplasia in north India. Int J Gynecol Pathol 2008 0.87
74 Growing evidence that HPV infection is associated with an increase in HIV acquisition: exploring the issue of HPV vaccination. Sex Transm Infect 2013 0.86
75 Indian women with higher serum concentrations of folate and vitamin B12 are significantly less likely to be infected with carcinogenic or high-risk (HR) types of human papillomaviruses (HPVs). Int J Womens Health 2010 0.86
76 Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities. Cancer Epidemiol Biomarkers Prev 2013 0.86
77 Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management. Mod Pathol 2012 0.85
78 Evaluation of adjunctive tests for cervical cancer screening in low resource settings. Indian J Cancer 2007 0.85
79 Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples. BMC Public Health 2008 0.85
80 Comparison of normalization methods for measuring immune markers in cervical secretion specimens. J Immunol Methods 2012 0.85
81 A descriptive analysis of prevalent vs incident cervical intraepithelial neoplasia grade 3 following minor cytologic abnormalities. Am J Clin Pathol 2012 0.85
82 Shedding of Epstein-Barr virus and cytomegalovirus from the genital tract of women in a periurban community in Andhra Pradesh, India. J Clin Microbiol 2011 0.84
83 Menstrual cycle and detectable human papillomavirus in reproductive-age women: a time series study. J Infect Dis 2013 0.84
84 Differences in patterns of high-risk human papillomavirus infection between urban and rural low-resource settings: cross-sectional findings from Mali. BMC Womens Health 2013 0.84
85 Characterizing the temporal dynamics of human papillomavirus DNA detectability using short-interval sampling. Cancer Epidemiol Biomarkers Prev 2013 0.84
86 Evaluation of any or type-specific persistence of high-risk human papillomavirus for detecting cervical precancer. J Clin Microbiol 2011 0.83
87 Prevalence of Anal High-Risk Human Papillomavirus Infections Among HIV-Positive and HIV-Negative Men Who Have Sex With Men in Nigeria. Sex Transm Dis 2016 0.82
88 Comparison of the immune microenvironment of the oral cavity and cervix in healthy women. Cytokine 2013 0.82
89 Detection of human papillomavirus from self-collected vaginal samples of women in Chiang Mai, Thailand. Sex Transm Dis 2008 0.81
90 Human papillomavirus prevalence and cytopathology correlation in young Ugandan women using a low-cost liquid-based Pap preparation. Diagn Cytopathol 2010 0.80
91 Obesity and human papillomavirus infection in perimenopausal women. J Infect Dis 2013 0.80
92 High-risk human papillomavirus prevalence is associated with HIV infection among heterosexual men in Rakai, Uganda. Sex Transm Infect 2012 0.79
93 Human papillomavirus genotypes detected in clinician-collected and self-collected specimens from women living in the Mississippi Delta. BMC Infect Dis 2013 0.78
94 Acceptability of HPV vaccine implementation among parents in India. Health Care Women Int 2013 0.77
95 Frequent detection of HPV before and after initiation of antiretroviral therapy among HIV/HSV-2 co-infected women in Uganda. PLoS One 2013 0.77
96 Validation of a low-cost, liquid-based screening method for cervical intraepithelial neoplasia. Am J Obstet Gynecol 2006 0.75
97 Trends in head and neck cancers in Peru between 1987 and 2008: Experience from a large public cancer hospital in Lima. Head Neck 2013 0.75